Physician profile
Letitia Meyer
NPI 1467978189
$1,103.69
in general payments reported to CMS, 2019-2025
14 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $32.11 · 2023: $329 · 2024: $339 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $244.60 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $178.69 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $156.56 | 2022-2025 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $141.34 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.06 | 2024-2025 | Xifaxan, Trulance |
| Amgen INC. | $68.69 | 2023-2024 | Repatha, Otezla |
| Abbott Laboratories | $50.43 | 2025 | Freestyle Libre 2 |
| Otsuka America Pharmaceutical, INC. | $33.72 | 2024 | Rexulti |
| Pfizer INC. | $32.68 | 2023-2024 | |
| Exact Sciences Corporation | $32.66 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $19.93 | 2024 | |
| Kyowa Kirin, INC. | $18.38 | 2024 | Crysvita |
| Corcept Therapeutics | $17.38 | 2024 | Korlym |
| Phathom Pharmaceuticals, INC. | $12.57 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Letitia Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.